Reduced nitric oxide in diabetic kidneys due to increased hepatic arginine metabolism: implications for renomedullary oxygen availability
Authors:
- Fredrik PalmFPFredrik Palm
- Malou FriederichMFMalou Friederich
- Per-Ola CarlssonPCPer-Ola Carlsson
- Peter HansellPHPeter Hansell
- Tom TeerlinkTTTom Teerlink
- Per LissPLPer Liss
- 1 January 2008
- journal article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 294 (1) , F30-F37
Abstract
Nitric oxide (NO) is a potent regulator of both vascular tone and oxygen utilization. Diabetes is commonly associated with both NO deficiency and reduced renomedullary oxygen availability. Arginine availability as regulator of NO production has gained growing interest. We hypothesized that arginine limitation causes diabetes-induced renomedullary NO deficiency, which directly influences renomedullary oxygen tension (Po2). Medullary NO, Po2, and blood flow were measured in control and streptozotocin-induced diabetic rats, which were treated or not treated with α-tocopherol, and administered l-arginine followed by Nω-nitro-l-arginine methyl ester. Major components of arginine metabolism were also investigated. Diabetic rats had reduced renomedullary NO levels compared with controls. Arginine selectively increased NO levels in diabetic rats and totally restored NO levels in α-tocopherol-treated animals. Tocopherol prevented the reduction in medullary Po2 in the diabetic animals. Although blood flow increased equally in all groups, arginine increased Po2 exclusively in the diabetic groups. Diabetes decreased plasma arginine and asymmetric dimethylarginine concentrations, but increased hepatic CAT-2A and plasma ornithine independently of α-tocopherol treatment. In conclusion, diabetic rats had reduced renomedullary NO due to decreased plasma arginine following increased hepatic arginine uptake and degradation. This was unrelated to oxidative stress. The diabetes-induced reduction in renomedullary Po2 was restored by either acute arginine administration, which also restored NO levels, or long-term antioxidant treatment. Arginine increased medullary NO and Po2 independently of altered hemodynamics in the diabetic groups. This reveals a direct regulatory function of NO for renomedullary Po2 especially during situations of elevated oxidative stress.Keywords
This publication has 44 references indexed in Scilit:
- Nitric Oxide Modulates Oxygen Sensing by Hypoxia-inducible Factor 1-dependent Induction of Prolyl Hydroxylase 2Journal of Biological Chemistry, 2007
- Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic columnAnalytical Biochemistry, 2006
- Role of endothelial nitric oxide in microvascular oxygen delivery and consumptionFree Radical Biology and Medicine, 2005
- Modeling the influence of superoxide dismutase on superoxide and nitric oxide interactions, including reversible inhibition of oxygen consumptionFree Radical Biology and Medicine, 2003
- Can We Model Nitric Oxide Biotransport? A Survey of Mathematical Models for a Simple Diatomic Molecule with Surprisingly Complex Biological ActivitiesAnnual Review of Biomedical Engineering, 2001
- Endothelial nitric oxide synthase plays an essential role in regulation of renal oxygen consumption by NOAmerican Journal of Physiology-Renal Physiology, 2001
- Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic RabbitsBiochemical and Biophysical Research Communications, 1996
- Hypoxia of the Renal Medulla — Its Implications for DiseaseNew England Journal of Medicine, 1995
- The Measurement of Nitric Oxide Release Induced by Kainic Acid Using a Novel Hemoglobin‐trapping Technique with MicrodialysisaAnnals of the New York Academy of Sciences, 1994
- The plasma flux and oxidation rate of ornithine adaptively decline with restricted arginine intake.Proceedings of the National Academy of Sciences, 1994